Arrhythmia Patterns in Patients on Ibrutinib
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.792310
Abstract: Introduction: Ibrutinib, a Bruton's tyrosine kinase inhibitor (TKI) used primarily in the treatment of hematologic malignancies, has been associated with increased incidence of atrial fibrillation (AF), with limited data on its association with other tachyarrhythmias.… read more here.
Keywords: ibrutinib therapy; patients ibrutinib; burden patients; arrhythmia patterns ... See more keywords